BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35818653)

  • 1. Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital.
    Lie KC; Shakinah S; Pasaribu A; Sinto R; Nainggolan L
    Acta Med Indones; 2022 Apr; 54(2):161-169. PubMed ID: 35818653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
    Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
    BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission.
    Antuori A; Giménez M; Linares G; Cardona PJ
    Sci Rep; 2023 Nov; 13(1):19302. PubMed ID: 37935785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
    J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
    Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya.
    Asmarawati TP; Rosyid AN; Suryantoro SD; Mahdi BA; Windradi C; Wulaningrum PA; Arifianto MV; Bramantono B; Triyono EA; Rusli M; Rachman BE; Marfiani E; Endraswari PD; Hadi U; Kuntaman K; Nasronudin N
    F1000Res; 2021; 10():113. PubMed ID: 33868645
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
    Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
    Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications.
    Ul Mustafa Z; Batool A; Ibrar H; Salman M; Khan YH; Mallhi TH; Meyer JC; Godman B; Moore CE
    Expert Rev Anti Infect Ther; 2024 Apr; 22(4):229-240. PubMed ID: 38146949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario.
    Bassetti M; Brucci G; Vena A; Giacobbe DR
    Expert Opin Pharmacother; 2023; 24(15):1679-1684. PubMed ID: 37466425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.
    Martin AJ; Shulder S; Dobrzynski D; Quartuccio K; Pillinger KE
    J Pharm Pract; 2023 Apr; 36(2):256-263. PubMed ID: 34291681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.
    Lee J; Chang E; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Bae S
    J Korean Med Sci; 2023 Jan; 38(4):e37. PubMed ID: 36718563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
    Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
    PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.
    Maki KR; Steiger SN; Su Y; Boumiza A; Tan CA; Kerpelev M; Seo SK; Cohen N
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):413-419. PubMed ID: 35616016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial infection, antibiotic use and COVID-19: Lessons from the intensive care unit.
    Moolla MS; Reddy K; Fwemba I; Nyasulu PS; Taljaard JJ; Parker A; Louw EH; Nortje A; Parker MA; Lalla U; Koegelenberg CFN; Allwood BW
    S Afr Med J; 2021 Apr; 111(6):575-581. PubMed ID: 34382570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.